CLINICAL_TRIALS
trial_result
· 2025-08-27
Clinical Trial Update: Efficacy and Safety of Lomitapide in Paediatric Patients With Homozygous Familial Hypercholesterolaemia (HoFH) [Phase 3]
Summary
Phase 3 trial evaluating lomitapide in pediatric patients with Homozygous familial hypercholesterolemia has completed. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amryt Pharma | Conditions: Homozygous Familial Hypercholesterolaemia (HoFH) | Phase 3 | Status: COMPLETED | Results posted: 2025-08-27